Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • The New Recommendations For Prostate Cancer Screenings Are A Bad Deal

    STAT | New draft guidelines for PSA screening aren't an endorsement for the test. Whether or not to have it is a difficult choice for men and their doctors.

    Apr 11, 2017
  • FDA Signs Collaborative Agreement With Emulate To Use Organ’s-On-Chips Technology As Toxicology Testing Platform

    Diagnostics World | Emulate announced today that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration’s Office of Foods and Veterinary Medicine in order to use Emulate’s Organ’s-on-Chips technology for toxicology testing in food, dietary supplements, and cosmetic products.

    Apr 11, 2017
  • Illumina Introduces Veriseq NIPT Solution In The European Union

    Diagnostics World Brief | Illumina today announced the launch of the VeriSeq NIPT Solution, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.

    Apr 10, 2017
  • Mercks Diabetes Franchise And The Perils In Proving A Drugs Medical Value

    Forbes | To get good pricing for a new medicine, you have to prove its value. In these two examples, Lilly came out on top.

    Apr 7, 2017
  • Scott Gottlieb’s FDA Commissioner Confirmation Hearing Remarkably Unremarkable

    Health Affairs | Scott Gottlieb's FDA Commissioner Confirmation Hearing: Remarkably Unremarkable | At the intersection of health, health care, and policy.

    Apr 7, 2017
  • 23andMe Receives FDA Authorization To Return Genetic Risks For Ten Diseases

    Diagnostics World News Brief | 23andMe today announced that the U.S. Food and Drug Administration (FDA) granted the company the first authorization to market genetic reports on personal risk for certain diseases. The authorization includes reports on genetic risk for ten conditions, including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease and hereditary thrombophilia (harmful blood clots), among others.

    Apr 6, 2017
  • Digital Antibiotic Susceptibility Testing: A More Efficient Way To Test Antibiotic Resistance

    Diagnostics World | Travis Schlappi, the winner of the inaugural Early Innovator Award, has developed a digital susceptibility test that would allow doctors to determine the antibiotic resistance profile of an infection before prescribing an antibiotic.

    Apr 5, 2017
  • EU Parliament Adopts New Medical Device IVD Regulations

    RAPS | The EU's effort to overhaul the regulation of medical devices and in vitro diagnostics (IVDs) has cleared its final legislative hurdle after the European Parliament on Wednesday adopted the proposed regulations without amendment.

    Apr 5, 2017
  • numares Announces Commercial Launch Of renalTX-SCORE

    Diagnostics World Brief | numares today announced the commercial launch of its new non-invasive test renalTX-SCORE for the diagnosis of kidney rejection. It is the first test available worldwide evaluating a metabolic biomarker network rather than single biomarkers or tissue biopsy for the diagnosis of an acute rejection reaction following a kidney transplant.

    Apr 4, 2017
  • Invitae Announces Introduction Of Exome Testing

    Diagnostics World Brief | Invitae has announced a major expansion of its genetic testing services with the introduction of exome sequencing and interpretation services, bringing the company's available test menu to more than 20,000 genes.

    Apr 3, 2017
  • HudsonAlpha, JAX, Thermo Fisher, And More: News From March 2017

    Diagnostics World Brief | News, products, and partnerships from around the diagnostics community including news from HudsonAlpha, JAX, Thermo Fisher, and more.

    Mar 31, 2017
  • Association for Molecular Pathology Publishes Cancer Sequencing Recommendations

    Diagnostics World Last week, the Association for Molecular Pathology (AMP) published consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients. The report, “Guidelines for Validation of Next Generation Sequencing (NGS)-based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists,” was released online in The Journal of Molecular Diagnostics.

    Mar 30, 2017
  • The Screen Project Launches BRCA Screening Across Canada

    Diagnostics World | A group of researchers in the Familial Breast Cancer Research Unit at Women’s College Hospital in Toronto, Canada, are launching a population-based study called The Screen Project that will offer genetic testing for BRCA1 and BRCA2 gene mutations to any Canadians over the age of 18 for $165 USD.

    Mar 29, 2017
  • Consumption Junction: Changing Tuberculosis Through Diagnostics

    Diagnostics World News | An ancient disease has brought the world to a modern-day crossroads. Here's how improved diagnostics could head off the tuberculosis epidemic.

    Mar 22, 2017
  • Kailos, Illumina Sign Co-Marketing Agreement For Pharmacogenetic Tests

    Diagnostics World Brief | Kailos Genetics and Illumina have entered a co-marketing agreement with Illumina. Under the terms of the agreement, Illumina will market and promote the Kailos TargetRich line of research solutions for pharmacogenetics targets through its commercial channels.

    Mar 21, 2017
  • Winners Selected For 2nd Annual Swimming With The Sharks Competition

    Diagnostics World | Deton, Geneoscopy, and Selfdiagnostics were all announced as winners of the 2nd annual Swimming with the Sharks competition at this year’s Molecular Medicine Tri-Conference.

    Mar 21, 2017
  • Google+ Creator Heart Tracking Device Startup AliveCor Gets $30 Million Funding

    Silicon Valley Business Journal | AliveCor's pocket-sized EKG monitor connects to smartphones and can get someone a picture of the electrical activity in their heart in 30 seconds. AliveCor is also launching Kardia Pro, an artificial intelligence platform that links weight and activity level to build a personalized heart profile.

    Mar 17, 2017
  • WHO's Priority List Of Antibiotic-Resistant Bacteria Looks Beyond Tuberculosis

    STAT | Tuberculosis is a global priority for the World Health Organization. But it must also pay attention to threats from other antibiotic-resistant bacteria.

    Mar 13, 2017
  • «
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167 (current)
  • 168
  • 169
  • 170
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy